BACKGROUND: Bariatric surgical procedures, including the laparoscopic adjustable gastric band (LAGB), are currently the only effective treatments for morbid obesity, however, there is no clear understanding of the mechanisms underpinning the efficacy of LAGB. The aim of this study is to examine changes in activation of the sensory neuronal pathways and levels of circulating gut hormones associated with inflation of an AGB. DESIGN AND RESULTS: The trajectory within the central nervous system of polysynaptic projections of sensory neurons innervating the stomach was determined using the transsynaptically transported herpes simplex virus (HSV). Populations of HSV-infected neurons were present in the brainstem, hypothalamus and cortical regions associated with energy balance. An elevation of Fos protein was present within the nucleus of the solitary tract, a region of the brainstem involved in the control of food intake, following acute and chronic band inflation. Two approaches were used to test (1) the impact of inflation of the band alone (on a standard caloric background) or (2) the impact of a standard caloric meal (on the background of the inflated band) on circulating gut hormones. Importantly, there was a significant elevation of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY) following oral gavage of a liquid meal in animals with pre-inflated bands. There was no impact of inflation of the band alone on circulating GLP-1, PYY or ghrelin in animals on a standard caloric background. CONCLUSION: These data are consistent with the notion that the LAGB exerts its effects on satiety, reduced food intake and reduced body weight by the modulation of both neural and hormonal responses with the latter involving an elevation of meal-related levels of GLP-1 and PYY. These data are contrary to the view that the surgery is purely 'restrictive'.
INTRODUCTION
Bariatric surgery is now well established as a safe and effective treatment for morbid obesity (body mass index X40 or a body mass index of at least 35 with one or more severe comorbid conditions). This is a necessity resulting from the failure of lifestyle interventions centred on diet and exercise that produce small (approximately 5 -10%) and transient reductions in body weight. 1 Similarly, pharmacotherapies, even in conjunction with positive lifestyle changes, offer only slightly better shifts in body weight. 2, 3 Despite a recent diversification in surgical approaches seeing increased focus on procedures, such as vertical sleeve gastrectomy (VSG) and biliopancreatic diversion, the most commonly performed bariatric operations remain the Roux-en-Y gastric bypass (RYGB) and the laparoscopic adjustable gastric band (LAGB). Comparison of RYGB and LAGB indicates that approximately the same percentage of excess weight loss occurs after 8 years, although the former produces significantly greater weight loss in years 1 and 2 postoperatively. 4 Although the efficacy of these two surgeries in producing profound weight loss was initially attributed to restriction of food entering the stomach (LAGB) or a combination of malabsorption and restriction (RYGB), it is becoming increasingly apparent that neural and humoral factors are brought into action to mediate surgery---induced weight loss. 5 -8 It is even more likely that a complex interplay of peripheral mechanisms is operating to improve glucose metabolism and alleviate type 2 diabetes particularly in the short term following RYGB. 9, 10 The improvement of diabetic status resulting from LAGB on the other hand seems to be more clearly proportional to weight loss. 11 The complexity of the putative mechanisms underlying the efficacy of different forms of bariatric surgery, as well as the rigour and invasiveness necessary to properly investigate them, requires the development of animal models. Recent successful models have centred on RYGB, 12 VSG 5 and to a lesser extent LAGB. 13 -15 The latter as it is applied to rodent models has fallen short of replicating some of the essential elements of the human band. For example, most were simple restrictive ties 14 without the potential to adjust the band to determine optimum impact on food intake and weight loss. We recently developed a model 16 that broadly recapitulates the human procedure where the band is applied just below the rat gastro-oesophageal junction creating a gastric pouch proximal to the inflated band. Additionally, the band is inflatable via a peripherally placed port, meaning that effective weight loss can be titrated with variable inflation. The last of these characteristics allows acute measurements of peripheral and central neural properties in un-anaesthetized animals.
The present study utilizes this model to describe acute changes in neural and humoral factors subsequent to band inflation. More specifically, changes in the activity of the central neural pathways and the release of gut-derived hormones were assessed in the period immediately following inflation of the band.
MATERIALS AND METHODS Animals
Adult male Sprague-Dawley rats (12 -16 weeks, 275 -325 g, Animal Resources Centre, Perth, Western Australia, Australia) were housed under a 12 h:12 h light:dark cycle and temperature-controlled environment (22 -23 1C) with free access to the standard rat chow and water.
Herpes simplex virus (HSV) strain 129
In order to evaluate the distribution of the sensory neural pathways that may be recruited by the inflation of the AGB at the gastro-oesophageal junction, the transneurally transported mutant form of the HSV (H129) was injected into the regions of the stomach directly under the band. Normally, HSV is transported from sensory ganglia along peripheral processes to cause recurrent eruptions on oral surfaces. 17 In rare and potentially fatal situations, transport of virus occurs via centrally directed processes of sensory neurons resulting in central nervous system infections and encephalitis. Isolates from such patients have yielded an attenuated strain of HSV, strain 129 (H129).
18 H129 was shown to be transported transneuronally via vagal sensory neurons to postsynaptic target cells in the brainstem then eventually, depending on post-inoculation times, to other 'higher order' regions of the central nervous system. 19 Although it is commonly accepted that H129 is transported exclusively in sensory neurons, an exception was identified by Rinaman et al., 19 whereby there is first-order retrograde infection of neurons situated in the dorsal motor nucleus of the vagus that project directly to the stomach. It is clear, however, that transport is restricted to these neurons and further transsynaptic transport in the retrograde direction does not occur.
Injection of H129 into the stomach
All experimental procedures were performed in a PC3 biocontainment facility and approved by the School of Biomedical Sciences animal ethics committee at Monash University. HSV H129 (1 Â 10 10 pfu ml À1 , provided by Dr Richard Dix) was injected via a 10-ml Hamilton syringe (Hamilton Company, Reno, NV, USA) angled tangentially between the muscle layers of the stomach wall. Injections were made at multiple sites, injecting 2 ml each time to a total volume of 10 ml per animal. Virus was injected along the dividing ridge that separates the amotile forestomach from the glandular stomach overlapping the area where the adjustable gastric band is placed in the animal model. The Hamilton syringe was left in place after each injection for at least 5 min to promote diffusion of the virus away from the needle tip and minimize efflux and contamination of adjacent tissues. After the last injection, the stomach wall was rinsed with saline several times, swabbed dry to remove any virus from the surface of the stomach and returned to the abdominal cavity. Planned survival times varied between 3 and 6 days.
Perfusion and tissue preparation from HSV inoculation
After the designated survival time, rats were deeply anaesthetized and perfused transcardially with 4% paraformaldehyde in phosphate buffer. Brains were post fixed at 4 1C overnight in the fixative, cryoprotected and 35 mm coronal sections were cut using a freezing microtome.
Immunocytochemical procedures for HSV labelling
Free-floating sections were exposed to standard immunocytochemical protocols to identify HSV-positive neurons. Essentially, sections were incubated overnight in phosphate buffer containing 0.1% Triton X-100, 1% normal horse serum and antisera raised against HSV (rabbit anti-HSV-1, 1:10 000, DakoCytomation, Glostrup, Denmark). Sections were then incubated in phosphate buffer containing affinity-purified fluorescenttagged secondary antisera (Texas Red-conjugated donkey anti-rabbit, 1:800; Jackson ImmunoResearch, West Grove, PA, USA) for 90 min after which they were rinsed and mounted on glass slides.
Double labelling of HSV---positive neurons with feeding-related hormones
In order to characterize the neurochemical content of HSV-labelled neurons, brain sections were incubated overnight with antisera raised against either orexin A (1:1000; Calbiochem, San Diego, CA, USA) or melanin-concentrating hormone (1:2000; Calbiochem). Sections were then incubated in phosphate buffer containing affinity-purified fluorescenttagged secondary antisera (FITC-conjugated donkey anti-goat, 1:500; Jackson ImmunoResearch) for 90 min.
Implantation and inflation of the adjustable gastric band
The AGB used throughout these experiments is a commercially available (In Vivo Metric, Healdsburg, CA, USA) vascular occluding device consisting of a silicone ring (14 mm diameter) with an inflatable inner lining and a tubing extension. This device has key characteristics (inflatable inner cuff, position at gastro-oesophageal junction and external port for inflation/ deflation of band) in common with that used in LAGB procedures in human surgeries and has been described previously. 16 The length of tubing, continuous with the inner inflatable portion of the cuff, can be directed out of the peritoneum, threaded subcutaneously and externalized in the dorsal neck region. This arrangement allows inflation of the cuff in the conscious lightly restrained rat by injecting a pre-calibrated volume of saline into the externalizing tubing via a 1 ml syringe.
In order to implant the AGBs, rats were anaesthetized with isoflurane (Isorrane, Baxter Healthcare, Old Toongabbie, New South Wales, Australia) after an overnight fast. The stomach was exposed via a midline abdominal incision and the forestomach inverted by either folding it in a pleat-like fashion or completely resecting the forestomach and then suturing with a series of interrupted sutures (6-0 silk; Dynek, Hendon, South Australia, Australia). This is necessary to circumvent the accumulation of food and obstruction in the relatively non-motile squamous portion of the stomach that may arise subsequent to band inflation. The open AGB was then placed around the glandular stomach below the insertion of the oesophagus immediately distal to the gastro-oesophageal junction indicated by the dividing ridge. An additional two sutures were used to secure the gastric fundus around the band in order to prevent the band from slipping. The band tubing was externalized between the scapulae and secured through an accessible port that allowed inflation and deflation of the band in the conscious animal. In order to investigate the impact of chronic band inflation, rats were fitted with bands and compared with sham-operated animals (removal of forestomach). The use of sham-operated animals as a comparison aimed at circumventing problems associated with constriction of the growing stomach by the uninflated band as comparison over 6 experimental weeks.
Rats with fitted bands had 0.4 ml of saline injected into the AGB via the tubing connected to the externalized port in the dorsal aspect of the neck. This resulted in a 25% reduction of area under the band. The tubing was folded and tied with silk to establish a seal and maintain a constant pressure within the inflated AGB over time.
Identification of activated neural circuits (using elevated levels of Fos protein as a marker of activity) following inflation of the AGB Acute inflation: Twelve rats fitted with AGBs were divided into two equal groups. On the day of the experiment, food was removed from all rats at the beginning of the light phase. After 4 h, one group (n ¼ 6) had bands inflated (see above), whereas the others were handled in the same way but their bands were not inflated. After 2 h, all rats were perfused transcardially with 4% paraformaldehyde, brains removed and fixed overnight.
Chronic inflation: AGBs were optimally inflated in line with previously published data 16 in a subset of animals. Body weight and food intake were measured over a period of 45 days. On day 45, rats (n ¼ 8) were perfused transcardially with 4% paraformaldehyde and brains removed and fixed overnight. Histological brain sections from rats with either acutely or chronically inflated bands were cut in a coronal plane at a thickness of 35 mm through the hypothalamus and brainstem using a freezing microtome. Free-floating sections were processed using the standard immunocytochemical approaches to identify Fos immunoreactive elements. Sections were exposed to a primary antibody raised in rabbit against residues 2 -17 of human Fos (diluted 1:8000; Santa Cruz Biotechnology, Santa Cruz, CA, USA). After incubation of sections in primary antisera for 48 h at 4 1C, sections were exposed to Fos antisera, which were localized with an immunoperoxidase method resulting in a brown reaction product, in reactive nuclei.
Cell counts and data analysis: The extent of labelling of Fos-positive neurons was quantified in specific brain regions in the hypothalamus and brainstem. Counts of labelled neurons in the hypothalamus (arcuate nucleus, paraventricular nucleus of the hypothalamus and lateral hypothalamic area) and forebrain (insular cortex) were made by an observer blind to the treatment of the groups according to the boundaries defined in Paxinos and Watson. 20 For the nucleus of the solitary tract (NTS), distinctions were made between rostral (À12.00 to À13.00 mm from bregma), mid (À13.00 to À14.00 from bregma) and caudal (À14.00 to À14.60 mm from bregma) regions.
Femoral artery cannulation for gut-hormone assays
In order to determine plasma gut-hormone levels, rats were prepared with vascular cannulae to allow collection of blood samples at discrete times following either inflation of the AGB alone (on a standard caloric background) or after a standardized meal on the background of inflated or uninflated bands. On the day of AGB surgery, each animal was fitted with a silastictipped vinyl cannula in the left femoral artery. The cannula was routed under the skin, exteriorized at the same port as the tubing extension from the AGB and capped. Each cannula was filled with heparinized saline (250U ml À1 ) containing antibiotic (20 mg ml À1 gentamicin; Sigma, Steinheim, Germany). During the 7-day recovery period, the cannula was flushed every second day with gentamicin in heparinized saline.
Experimental protocol for assessment of gut hormones
In order to determine the impact of inflation of the band alone on specific gut hormones, rats (n ¼ 12) with fitted AGBs were used. Three hours following gavage of a standard liquid caloric meal (45 kJ in 5 ml; 18% protein, 39% fat and 43% carbohydrate; Novasource 2.0, Nestle Nutrition, Sydney, New South Wales, Australia) to ensure a common caloric baseline for all rats, baseline blood samples (0.3 ml, immediately replaced with an equal volume of heparinized saline) were taken from all rats. Immediately, following blood collection, rats (n ¼ 6) had their bands inflated to a predetermined optimal level, whereas the remaining rats (n ¼ 6) were sham-handled and their bands were left uninflated. Blood was taken via an externalized tubing extension from femoral cannula while the rats were in their home cages without restraint. Consecutive blood samples were taken at 30, 60 and 120 min, respectively, following band inflation and at corresponding times for those rats with uninflated bands. All blood samples were collected into EDTA tubes (K3EDTA, 1 ml; Greiner Bio-One GmbH, Kremsmuenster, Austria) that were pretreated with protease inhibitors (DPPIV Inhibitor: Millipore, Billerica, MA, USA, Cat. no. DPP4 or DPP4-010, 1:100 final dilution in whole blood; Protease Inhibitor Cocktail: Sigma, Cat. no. P2714, 1:1000 dilution in whole blood). Blood samples were kept on ice for a maximum of 15 min until centrifuged and the plasma aliquots then stored at À80 1C for subsequent assays to determine circulating gut hormone concentrations.
In order to assess the impact of a standard caloric meal on the background of an inflated band on specific gut hormones, a separate group of rats fitted with AGBs were fed by gavage a standard liquid meal 3 h after band inflation, allowing for standardization of caloric content and timing or sham-handled without inflation. Each rat in the experimental group (n ¼ 4) had 0.4 ml of saline injected into the AGB 2 h into the light phase following an overnight fast. Baseline blood samples (0.3 ml, immediately replaced with an equal volume of heparinized saline) were taken from all rats immediately followed by a standardized liquid meal given by oral gavage (45 kJ, as above). Consecutive blood samples were taken at 30, 60 and 120 min, respectively, following the meal. All blood samples were collected in EDTA-coated tubes containing protease inhibitors (as described above). Following the final blood collection, all bands were deflated and rats were allowed free access to chow. The experiment was repeated after 7 days in a cross-over design.
Assays for gut-hormone study A Lincoplex kit (Rat gut-hormone panel, Cat. no. RGT-88K, Millipore) was used for simultaneous multi analyte detection and measurement of ghrelin (active), peptide YY (PYY) and glucagon-like peptide-1 (active, GLP-1). The detection limit for ghrelin was 2 pg ml À1 and the intra-and inter-assay coefficients of variations were 7.4% and 8.1%, respectively. The detection limit for PYY was 16 pg ml À1 , and the intra-and inter-assay coefficients of variations were 3.2% and 7.7%, respectively. The detection limit for GLP-1 was 41 pg ml À1 and the intra-and inter-assay coefficients of variations were 6.5% and 7.9%, respectively. For each experiment, care was taken to ensure an equal distribution of groups between individual plates. In situations such as that described for the impact of the band alone (not coincident meal but with a common caloric background ensured by the introduction by gavage of 45 kJ of a liquid diet 3 h prior to inflation), levels of GLP-1 were below the limits detectable with the Lincoplex kit. In these situations, ELISA (Shibayagi, Shibukawa, Japan) was used to determine levels of GLP-1, which has a detection limit of 1.56 pg ml À1 .
Statistics
Results are shown as mean ± s.e.m. The statistical software package SPSS v.16.0 (SPSS Inc., Chicago, IL, USA) was used to conduct all analyses.
Comparative statistical analyses were performed using a repeated measures analysis of variance for assessment of changes in body weight and gut hormones with Bonferroni post-hoc analysis to test the significance at each time point when a treatment by time interaction was observed or a main effect of treatment was observed. In the case of assessment of number of Fos-positive neurons, a repeated measures analysis of variance was used to assess changes throughout the NTS. When a main effect of treatment was observed, an unpaired t-test was performed to determine the level where differences exist. T-tests were performed to determine whether there are any differences in all other brain regions and assess changes in food intake and feed efficiency. Values of P o0.05 were regarded as significant.
RESULTS
Central trajectory of the sensory neuronal pathways directed to the region of the gastro-oesophageal junction (region immediately adjacent to the band) Data derived from 16 rats were used in these analyses. The live virus used in these experiments is transported transynaptically from primary sensory neurons innervating the stomach through synaptically-linked relays extending throughout the neuraxis from brainstem to cerebral cortex, thus allowing the mapping of the sensory pathways. The virus was targeted to the area of the stomach immediately subjacent and proximal to the band, which would likely be deformed by inflation of the AGB particularly, in conjunction with ingested meals. The central distribution of HSV-infected profiles changed with increasing post-inoculation time, so that additional synaptically connected shells of infection were identified as the planned survival time of the inoculated animals increased. There was some variability in the extent of central viral labelling between individual rats even within particular survival times, however, the distribution of labelled neurons was essentially the same. A survival time of 4 days showed first appearance of viral labelling in brainstem nuclei centred in the NTS (Figure 1a) . Following a survival time of up to 5 days, viral labelling extended beyond the NTS to include the medial and lateral portions of the parabrachial nucleus, locus coeruleus, lateral reticular formation, nucleus ambiguus and the dorsal motor nucleus of the vagus. Viral labelling 5 days following injection also extended into the hypothalamus and forebrain and was present specifically in the anterior and posterior parts of the parvicellular paraventricular nucleus of the hypothalamus (Figure 1c ), anterior and ventral portion of the bed nucleus of the stria terminalis and the basolateral amygdala. At this stage, small numbers of virally infected neurons were present in the perifornical area of the lateral hypothalamus (Figure 1d ) and the posterior part of the lateral hypothalamus. Light infection was also first apparent in the dorsomedial hypothalamus. When rats were allowed to survive for 6 days, numbers of virally infected neurons increased in each of the regions mentioned above and labelling was apparent in discrete thalamic nuclei (Figure 1e ) and in the posterior agranular insular cortex (Figure 1f) . Infected neurons were also present in the ventrolateral portion of the ventral medial hypothalamus, retrochiasmatic nucleus, arcuate nucleus ( Figure 1b) and ventral tegmental area.
Although most of the viral injections were centred on the gastro oesophageal junction and region immediately proximal to it, in a smaller number of animals (n ¼ 4), injections were made into the amotile forestomach. In these cases, the pattern of viral labelling throughout the brain stem and hypothalamus was essentially the same as that described above for the glandular stomach.
Colocalization of the sensory neural pathways with feedingrelated peptides In view of the fact that the central relays of sensory neurons innervating the gastro-oesophageal junction were well represented in the perifornical area of the hypothalamus and the likelihood that these pathways contain peptides responsible for the mediation of feeding, colocalization studies were performed using immunocytochemical detection of orexin A and melaninconcentrating hormone. Small numbers (o5%) of virally labelled neurons were found to only contain the orexigenic peptide orexin A, highlighting the association with the sensory pathways directed to the stomach (Figure 2) . No virally labelled neurons were found to contain melanin-concentrating hormone.
Detection of the activated sensory pathways following inflation of the AGB using elevated levels of Fos protein In order to assess the effect of AGB inflation on the central neural pathways, groups of rats (n ¼ 12) were fitted with AGBs and allowed to recover for at least 7 days. On the experimental day, rats were divided into two groups with one group having their bands inflated. Rats were killed 90 min following band inflation to test for the presence of elevated expression of Fos protein. The number of Fos-positive nuclei was significantly increased in the NTS, specifically toward the rostral part of the nucleus (Figures 3a  and f) following band inflation. Fos-positive nuclei were similarly elevated at other more caudal levels of the NTS, but these differences did not reach significance. These regions of the NTS corresponded to those containing transsynaptically transported HSV injected into the stomach wall in the vicinity of the AGB (Figure 4) . A range of hypothalamic nuclei including the lateral hypothalamic area/perifornical area, paraventricular nucleus of the hypothalamus and arcuate nucleus were assessed in a similar way, but no changes were detected between animals with inflated or uninflated bands. Similarly, no differences were apparent in the insular cortex between rats with and without inflated bands (Figures 3b -e) .
To determine the impact, if any, of the uninflated control band, an additional series of experiments were conducted where groups of rats (n ¼ 5) with inflated bands were compared with sham-operated animals where no bands were fitted (n ¼ 5). Counts of Fos-positive nuclei from each of the nuclei described above showed parallel changes in Fos expression with significantly elevated numbers in the rostral NTS but with no changes in other nuclei in the hypothalamus or cortex (data not shown).
In order to assess whether the neurons activated following acute band inflation are also recruited following chronic AGB inflation, a separate group of rats had their bands optimally inflated for 45 days. Rats with inflated AGBs (n ¼ 4) showed a significant reduction in body weight gain when compared with the control group (n ¼ 4) (Figure 5a ). In addition, rats with inflated AGBs consumed significantly less food and had a reduced feed efficiency over the 45 days of treatment (Figures 5b and d) . At the end of this treatment period, rats were killed to test for the presence of elevated expression of Fos protein. The number of Fos-positive nuclei was significantly increased in the NTS, specifically in the rostral and mid compartments of the nucleus (Figures 5c and e -g ).
Measurement of gut hormones following inflation of the AGB with and without a standard caloric meal Rats fitted with AGBs were challenged with either (1) inflation to a predetermined optimal level 3 h following gavage of a standard liquid caloric meal (45 kJ) or (2) fed by gavage of a standard caloric meal 3 h after band inflation. These two approaches were designed to test (1) the impact of inflation of the band alone on specific gut hormones (on a standard caloric background to eliminate variability of baseline levels of gut hormones) and (2) the impact of a standard caloric meal on the background of the inflated band on specific gut hormones. Circulating levels of GLP-1, PYY and active ghrelin were not altered in the 2-h period following inflation of the AGB compared with control animals with uninflated bands (Figures 6a -c) . By comparison, when a liquid meal was introduced 3 h following inflation of the band, there was a greater increase in circulating levels of GLP-1 and PYY compared with levels observed in rats fed with the same meal but without band inflation (Figures 6d and e) . Levels of GLP-1 and PYY were significantly increased in the experimental group at both the 30-and 60-min intervals following the liquid meal and in both cases returned to baseline levels 2 h after the meal. The expected reduction in circulating ghrelin levels following a meal was the same in rats with inflated and uninflated AGBs. The parallel reduction in ghrelin in both groups was evident at each of the time intervals after introduction of the meal (Figure 6f ).
DISCUSSION
The results described in this paper elucidate a number of factors that may be important in explaining the efficacy of the AGB as it is used in the treatment of morbid obesity in humans. They extend the observations of reduced food intake and body weight that we have made in a rodent model of an AGB 16 and others have made when non adjustable ligatures are applied to the gastrooesophageal junction in rodents. 13, 14 They look specifically at the acute and chronic changes associated with inflation of the band, taking advantage of its adjustable nature allowing assessment of the impact of perturbations on conscious animals. There are several major findings. Foremost among these is the description of elevated meal-related changes in GLP-1 and PYY following AGB inflation. Other key findings relate to the description of polysynaptic sensory neuronal relays projecting specifically to the area of the stomach affected by the application of the adjustable band and the identification of the Fos-positive brainstem pathways that are shown to be activated following either acute or chronic inflation of the AGB. The polysynaptic neural pathways were defined using a mutant form of HSV (H129 strain). The pathways identified in the present study were traced through their primary brainstem relay in the NTS, to hypothalamic nuclei, forebrain structures and finally to the cerebral cortex. These brain regions overlapped with those described previously in studies using the same virus injected more generally into the stomach. 20 Specifically in regard to the first synaptic relay, the stomach has been shown to receive afferent projections from subnuclei of the NTS, namely the medialis and gelatinosus regions. 21, 22 These areas directly overlap with the distribution of viral-labelled neurons detected in the present study. Higher-order labellings or infection of neurons beyond those in the NTS are also in agreement with those described in previous studies. These showed ascending connections of the NTS to numerous brain stem nuclei (that is, parabrachial nucleus) but also several forebrain structures (that is, bed nucleus of the stria terminalis and amygdaloid nucleus) and the hypothalamus, specifically to nuclei that are involved in the control of feeding and body weight. 23 -25 Each of the hypothalamic nuclei currently thought to be involved in food intake and integration of satiety signals arising from the periphery 26 -29 were found to contain substantial levels of viral labelling following the longest post-inoculation periods. Furthermore, infected neurons in the hypothalamus included those containing orexin A. The association of the sensory neural pathways projecting to the area under the band with the orexigenic peptide orexin A involved in the mediation of energy balance, 30 is consistent with the idea that recruitment of sensory afferents by inflation of the band has an impact on central hunger and satiety circuits.
Following inflation of the band, whether this be acute or chronic, there is an elevation of Fos protein indicative of increased neural activity in circumscribed regions of the brainstem, specifically in the NTS. Fos-responsive neurons were found predominantly in the rostral part of the nucleus corresponding to the nucleus gelatinosus where neurons labelled with virus following inoculation of the stomach were also most abundant. This again is consistent with the notion, described above, that vagally derived sensory afferents are involved in transmitting information about inflation of the band from stomach to the central nervous system. What is more surprising is that neurons in the hypothalamus and other parts of the sensory circuitry, arising from the stomach and defined using the viral technology, did not show significant elevation of Fos following AGB inflation compared with controls. These include regions, such as the insular cortex, shown to be implicated in sensory circuitry to the stomach both in our viral-tracking experiments and in functional magnetic resonance imaging studies following mechanical distortion of the stomach. 31 One reason why we could not detect elevations in Fos protein in neuronal populations beyond the brainstem relates to the fact that the intensity of immunocytochemically localized Fos is determined by the strength of the stimulus. 32 It may be assumed that if the activation of Fos is via a neurally activated sensory circuit, as we predict, there is some variability in the strength of synaptic input in the various relays throughout the neuraxis. This may see the activation of the immediate early gene c-fos and the transcription of Fos protein fall below detectable levels in regions beyond the NTS. It is possible, despite our assumption that activation of the NTS is via vagal sensory input, that NTS neurons are activated by a humoral link directly to the dorso-medial brainstem. However, when we measure changes in candidate gut-related hormones, such as GLP-1, PYY and ghrelin following band inflation alone, replicating the situation in our Fos experiments, there is no change in these entities beyond that seen in control animals with uninflated bands. The simplest explanation therefore is that band inflation in itself causes the activation of neurons in the NTS via inputs from vagal sensory fibres innervating the gastro-oesophageal region of the stomach.
What may be surprising to some is that activation of NTS neurons persists beyond the acute stimulus and registers in the same regions of the NTS after chronic inflation of the AGB. This is analogous to the durability of the deformation or pressure effect experienced in human patients, which is evidenced by the longterm sustained weight loss achieved with a properly adjusted band. Data to this effect are available for bands and other 'restrictive' surgeries that extend well beyond 10 years. 33, 34 The functional basis for the persistent satiation experienced in both banded humans and rats may lie in the recruitment of specialized slowly accommodating sensory vagal endings, intraganglionic laminar endings 35, 36 by deformation of the stomach resulting from inflation of the band with or without the additional stimulation of ingesta. Intraganglionic laminar endings have been described as specialized tension-sensitive mechanoreceptors that may also act as transmitter-release sites for synaptic interactions with enteric neurones, 36 and as such are prime candidates to explain the mechanosensitive aspects of band inflation.
One of the most intriguing issues uncovered in this study is the change in release of gut hormones when the inflation of the band is followed by a standard caloric meal. Here we found that the expected increase in the anorexigenic hormones PYY and GLP-1 following the meal was enhanced when combined with band inflation. This result is consistent with the increased satiety experienced by patients with optimally inflated gastric bands 37 and has not been demonstrated in rodent models of this surgery to date. If gut-hormone levels have been measured in these studies, the focus has been on ghrelin and the fact that gastric banding tends to prevent the increase in this hormone after caloric restriction. 38 By comparison, we found that levels of ghrelin were similarly reduced following a standard meal whether on the background of an inflated or uninflated band. Our data showing acute elevation of PYY and GLP-1 following band inflation and a meal were predictive of satiation and consistent with the reduced food intake observed in the rat model, however, the data generated from patients, albeit over longer time periods, have consistently shown no change in GLP-1 and PYY levels whether they have been measured 2 weeks or 1 year post surgery. 39 Although the differences between the human-and rat-banded data in regard to these hormones are difficult to reconcile, the possibility remains that they relate to technical issues associated with assays of the extremely labile hindgut hormones. There is no doubt that multiple sampling and assay procedures are easier to control in the experimental animal setting rather than the clinical human setting.
As noted above, the weight of data indicates that the AGB is not purely restrictive, 37 however, there remains a view that the AGB retards the transit of nutrients out of the stomach. If this were the case, one might expect the postprandial elevation in gut hormones to be reduced in the banded situation rather than elevated as shown in the current experiments. However, the delay in nutrient delivery in humans following gastroplasty and AGB is trivial. Gastric emptying is not delayed in humans and the pouch above the band empties in minutes. 40 -43 This observation underlies the non-restrictive nature of the AGB surgery.
It is also unclear as to the mechanisms whereby inflation of the band at the gastro-oesophageal junction may amplify hormones released from L cells in the distal gut. In this respect, cholinergic neural projections have been established between the foregut and hindgut that facilitate hormonal release that precedes the direct actions of nutrients on enteroendocrine L cells. 44 The mechanism that creates the biphasic hormonal response described to date is nutrient driven, 45 but it is conceivable that a similar pathway mediates the stretch-related effects of the band.
The data presented here are in keeping with the recent suggestion 46 that the LAGB exerts its effects on satiety, reduced food intake and reduced body weight by the modulation of both neural and hormonal responses where the latter involves elevation of gut hormones released in response to a meal. It would appear that band inflation alone invokes a neural response, which is likely to originate in the deformation of mechanoreceptors in the stomach and is propagated via the vagus nerve to the brainstem. In addition, when the band inflation is coupled with a standardized meal, there is a recruitment of a humoral effect involving the enhanced release of the anorexigenic hormones GLP-1 and PYY. These in all likelihood will interact with afferent endings to transmit satiation signals to the brain via the vagus nerve or possibly act directly on the brainstem. The challenge that is made practical through the use of animal models is to establish the central neural changes that underpin the satiety induced by band inflation. Importantly, these data underline the fact that the efficacy of the AGB is determined by factors other than restriction. An understanding of these mechanisms will not only enable a better insight into bariatric approaches but also further elucidate the nature of gut -brain interactions that subserve satiety.
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